The body clock is one of the most heavily measured systems in medicine and one of the least used. We counted both sides on 1 September 2026. ClinicalTrials.gov holds 1,232 registered studies involving circadian rhythm, 616 of them completed. It holds 80 involving chronotherapy — timing a treatment to that clock.
Roughly one study in fifteen turns the measurement into an intervention. A further 287 study shift work, which is the clock being broken rather than used.
The Nobel-winning biology below explains what the clock is made of. The registry shows how little of that understanding has yet changed when a drug is given.
On October 2, 2017, the Nobel Assembly at the Karolinska Institute in Stockholm announced that the Nobel Prize in Physiology or Medicine would be awarded jointly to three American scientists — Jeffrey C. Hall, Michael Rosbash, and Michael W. Young — for discoveries explaining one of the most fundamental and least appreciated systems in biology: the molecular mechanism that controls circadian rhythm, the roughly 24-hour internal clock that governs sleep, hormone release, body temperature, and metabolism in nearly every living cell.
The discovery answered a question that had puzzled biologists for over a century. Plants, animals, fungi, and even bacteria appear to anticipate the day-night cycle rather than simply reacting to it. A plant begins opening its leaves before sunrise. A person’s body temperature begins rising hours before they wake. This anticipatory behaviour suggested an internal clock — but for most of the twentieth century, nobody could explain what that clock was actually made of, or how it kept time with such precision using nothing but the chemistry inside a single cell.
Working with the common fruit fly, Drosophila melanogaster, Hall, Rosbash, and Young isolated the gene responsible and discovered the elegant molecular feedback loop by which it operates — a self-regulating cycle of protein production and degradation that repeats, with remarkable accuracy, roughly every 24 hours. Their work did not just solve a biological puzzle. It launched an entire field, chronobiology, that is now reshaping how medicine thinks about everything from cancer treatment timing to the genetics of aging itself.
The Century-Old Puzzle: Why Does Biology Run on a Clock?
The observation that living organisms follow daily rhythms is ancient — farmers and naturalists had noted it for thousands of years. The first rigorous scientific demonstration that this rhythm was internally generated, rather than simply a response to the rising and setting sun, came in 1729, when French scientist Jean-Jacques d’Ortous de Mairan observed that a mimosa plant continued opening and closing its leaves on a roughly 24-hour schedule even when kept in continuous darkness. Something inside the plant was keeping time without any external cue.
For the next two centuries, biologists confirmed this phenomenon across an enormous range of organisms — fungi, insects, birds, mammals, even single-celled algae — but the mechanism remained a complete mystery. The breakthrough that made a genetic explanation possible came in 1971, when Seymour Benzer and his graduate student Ronald Konopka, working at Caltech, identified fruit flies with mutations that disrupted their circadian rhythm entirely — some flies had no rhythm at all, others ran on a shortened or lengthened cycle.
They named the responsible gene period, or per. This was the first demonstration that a single gene could control an entire organism’s sense of time. But Konopka and Benzer could not isolate the gene itself or explain how it worked — the tools to do so did not yet exist.
1984: Isolating the Gene That Keeps Time
The decisive breakthrough came in 1984, when two independent research teams — Jeffrey Hall and Michael Rosbash working together at Brandeis University, and Michael Young working at Rockefeller University in New York — successfully isolated the period gene that Konopka and Benzer had identified thirteen years earlier.
Having the gene’s DNA sequence in hand allowed Hall and Rosbash to ask a far more powerful question: what does this gene actually do inside the cell, moment to moment, across a 24-hour cycle? In 1990, they published findings that would become the conceptual foundation of the entire field. They discovered that the protein encoded by the period gene — called PER — accumulates inside fly cells during the night and is broken down during the day, oscillating in a regular cycle that tracked the 24-hour rhythm precisely.
This observation led them to a remarkable hypothesis, one that turned out to be correct: PER protein, once it builds up to sufficient levels, travels back into the cell nucleus and blocks the activity of its own gene — shutting down its own production. As PER protein then gradually degrades, the inhibition lifts, the gene switches back on, and the cycle begins again.
This is a negative feedback loop, a concept borrowed from engineering and control theory, operating entirely within the chemistry of a single cell, with no external timekeeper required. The Nobel committee would later describe this self-sustaining loop as the conceptual turning point that explained, for the first time, how a biological clock could be built from molecules alone.
The Missing Piece: How Does PER Protein Get Into the Nucleus?
The feedback loop Hall and Rosbash described was elegant, but it left a critical gap. PER protein is produced in the cytoplasm of the cell — the fluid-filled space outside the nucleus. For it to block its own gene, it needs to physically travel into the nucleus, where the DNA is stored. What was controlling that journey, and why did it take so long — accumulating slowly enough to produce a roughly 24-hour cycle rather than a much faster one?
Michael Young’s laboratory at Rockefeller University answered this question in 1994 with the discovery of a second clock gene, which he named timeless, or tim. The protein it encodes, TIM, binds directly to PER protein. Only when bound together as a pair can the two proteins successfully enter the cell nucleus and shut down the period gene. This explained the missing mechanical step in the feedback loop — and also explained how the circadian clock could be reset by light, since TIM protein is rapidly broken down when exposed to light, allowing the clock to resynchronise with the external day-night cycle when needed, such as after crossing time zones.
Young’s laboratory then identified a third critical component in 1998: a gene called doubletime, encoding a protein called DBT, which delays the accumulation of PER protein, fine-tuning the speed of the entire cycle so that it runs close to 24 hours rather than completing much faster. Without this delaying mechanism, the feedback loop on its own would oscillate far too quickly. This discovery explained how the pace of the clock is adjusted — not just that a molecular clock existed, but how it could be calibrated with such precision across an entire organism and, eventually, across an entire species.
From Fruit Flies to Humans: The Mammalian Clock
The genetics uncovered in Drosophila turned out to be evolutionarily ancient and remarkably conserved. Within a few years of Hall, Rosbash, and Young’s discoveries, researchers identified equivalent clock genes in mice and humans — confirming that the same fundamental negative feedback architecture, refined over hundreds of millions of years of evolution, runs the circadian clock in essentially every cell of the human body, not just in the brain.
A particularly significant chapter in this story, often discussed alongside the 2017 Nobel Prize, involves Joseph Takahashi, then at Northwestern University, whose laboratory identified the mammalian Clock gene in 1994 through an enormous forward genetics screen in mice — a discovery that proved foundational to understanding the human circadian system and that some chronobiologists have argued deserved Nobel recognition alongside Hall, Rosbash, and Young. The Nobel Prize is limited to a maximum of three recipients per category, and the selection inevitably leaves out other scientists who made essential contributions to the same body of work — a structural limitation of the prize itself rather than a judgment on the relative importance of the excluded research.
In humans, the central circadian clock resides in a small region of the brain — the suprachiasmatic nucleus, located in the hypothalamus — which receives direct input from light-sensitive cells in the retina and synchronises the master clock to the external day-night cycle. But, and this was one of the most important downstream discoveries to follow the 2017 Nobel-winning work, nearly every cell in the human body contains its own independent molecular clock, built from homologous versions of the same period, timeless, and Clock genes, running with a degree of autonomy from the central brain clock. Your liver, your heart, your skin, and your immune cells each keep their own time.
The Reticular Activating System: The Brain’s Wakefulness Switch
Knowing what time it is, however, is not the same as being awake. The suprachiasmatic nucleus is a timer: it tells the body when wakefulness ought to happen. Producing the physical state of alertness is the work of a separate structure, the reticular activating system, a diffuse network of neurons running up through the brainstem into the thalamus. Experiments in 1949 established that wakefulness is not the brain’s default condition interrupted by sleep, but a state actively generated, moment to moment, by a specific circuit.
The two systems cooperate rather than overlap, and they fail independently in ways a clinician can tell apart. Damage confined to the suprachiasmatic nucleus destroys the daily rhythm of sleep and waking without necessarily preventing wakefulness itself. Damage to the reticular activating system, or the loss of the orexin-producing neurons that stabilise it, produces pathological sleepiness, narcolepsy or, after severe brainstem injury, coma — whatever the molecular clock happens to be doing. That dissociation is also why arousal and awareness are treated as separate problems, a distinction we take up in our piece on the hard problem of consciousness. Separating the clock that times wakefulness from the switch that produces it was the groundwork that made the molecular genetics legible.
The Suprachiasmatic Nucleus: Anatomy of the Master Clock
The phrase “master clock” is used loosely in popular science writing, but the suprachiasmatic nucleus earns it in a precise anatomical sense. It is a small paired structure, roughly the size of a grain of rice on each side, sitting directly above the optic chiasm in the anterior hypothalamus — that is, immediately above the point where the optic nerves cross. The position is not an accident. It places the clock directly in the path of light information arriving from the eyes.
Each side holds between 10,000 and 20,000 neurons, and the genuinely remarkable fact is easy to skim past: every one of them contains its own independent copy of the Hall-Rosbash-Young feedback loop, and every one can oscillate alone. Isolated, individual neurons drift out of phase with one another. What welds them into a single coherent tissue-level clock is chemical signalling between the cells, principally a peptide called vasoactive intestinal polypeptide together with vasopressin. The master clock is therefore not one timekeeping mechanism but thousands of identical ones held in step by conversation — a population rather than a device.
Light reaches it along a dedicated route, the retinohypothalamic tract, recognised only in the early 2000s as anatomically distinct from the pathway that forms images. It does not begin at the rods and cones. It begins at a small separate class of retinal cells carrying their own light-sensitive pigment, melanopsin, which respond to light with no input from rods or cones at all. This is why people who have lost all rod and cone function to retinal disease, and who are blind in the ordinary sense, can still entrain their body clock to the light-dark cycle. It also settled a puzzle first noticed in the 1920s, when mice bred without working rods and cones were found to keep their light-driven pupil reflexes.
In January 2026 researchers described the first working laboratory model of that human pathway, fusing retinal organoids with hypothalamic organoids into a connected assembloid. The point is translational. Rodents are the standard model for circadian biology, and rodents are nocturnal; their light-response physiology differs from ours in ways that have limited how directly findings transfer. A human tissue model of the light-to-clock connection closes part of that gap.
The Pineal Gland and Melatonin: How Darkness Becomes a Hormone
If the suprachiasmatic nucleus is the clock, the pineal gland is what broadcasts its verdict to the rest of the body in chemical form. It is a small pinecone-shaped structure deep in the centre of the brain, and its function was obscure for centuries. The answer proved less mystical than the speculation and, in its own way, just as remarkable: the pineal is the body’s primary site of melatonin production, and melatonin is the signal by which the clock’s sense of time becomes a body-wide instruction.
The route connecting the two is oddly indirect and took decades of neuroanatomical tracing to map. The signal leaves the suprachiasmatic nucleus, passes through the hypothalamus, descends the spinal cord and re-enters the head by way of a nerve cluster in the neck before arriving at the pineal. That detour is a fossil of evolutionary history. In many non-mammalian vertebrates the pineal is directly light-sensitive itself, a literal third eye; mammals lost the photosensitivity and kept the wiring.
Melatonin is built from tryptophan, the amino acid popularly blamed for post-lunch drowsiness, by way of serotonin. The enzyme that sets the pace of the whole pathway is itself under direct circadian control, its activity climbing sharply at night and falling during the day, which is why melatonin is sometimes called the hormone of darkness. Light falling on the retina at night suppresses its release directly: the clock’s chemical output can be switched off by a lamp.
Once in the bloodstream, melatonin acts on two receptor types distributed widely through the body, including back on the suprachiasmatic nucleus itself, where it appears to reinforce the very rhythm that produced it. That dual role, output and feedback at once, is why melatonin supplements taken at the right time can help reset timing after jet lag or in delayed sleep phase disorder, and why the same dose taken at the wrong time can push the clock further out of step.
A growing body of work connects this directly to neurodegeneration. A 2025 review in the journal Molecules, examining the molecular links between circadian disruption, melatonin and neurodegenerative disease, describes declining nighttime melatonin as a feature of ageing and sets out evidence that melatonin acts as a direct antioxidant and anti-inflammatory agent within the brain. On that reading, losing robust nighttime signalling removes a layer of protection against the protein aggregation and oxidative damage that drive these conditions.
Why Sunlight Matters So Much: Photoentrainment and the Modern Light Environment
The technical term for synchronising an internally generated rhythm to an external cue is entrainment, and for the circadian clock light is overwhelmingly the dominant cue. Left without any light cues at all — in experiments where volunteers lived for weeks with no clocks, no windows and no scheduled light — the human clock does not stop. It free-runs on its own natural period, which in most people is slightly longer than 24 hours.
Photoentrainment is the daily correction that keeps internal time locked to the rotation of the Earth: morning light advances the clock, evening light delays it. The retinal cells carrying that information are most sensitive to light of about 480 nanometres, in the blue-green part of the spectrum.
That sensitivity has an obvious modern consequence. The light-emitting diodes in phone, tablet and computer screens, and in most energy-efficient household lighting, emit a substantial share of their output near exactly the wavelength the clock is tuned to read as daylight. Evening screen use is therefore not simply a matter of being mentally stimulated; it is a timing signal.
The clinical application of this is most developed in seasonal affective disorder, a depressive condition linked to reduced winter light, for which carefully timed bright light treatment is an established therapy.
Body Temperature, Cortisol, and the Other Rhythms Your Clock Controls
The sleep-wake cycle is the most obvious circadian rhythm but far from the only one, and the others explain why circadian disruption produces such wide-ranging effects rather than simply making people tired.
Core body temperature follows a robust daily rhythm independent of activity, reaching its minimum in the early hours of the morning, roughly two hours before habitual waking. Because the suprachiasmatic nucleus generates this largely independently of the sleep-wake cycle itself, that temperature minimum is one of the most reliable physiological markers of underlying clock phase, and is used as such both clinically and in research.
The body’s central stress-hormone system is under the same control. Cortisol follows one of the most pronounced rhythms in human physiology, driven by direct neural projections from the suprachiasmatic nucleus to the hypothalamic neurons that govern the axis. The same genetic clock machinery first found in fruit flies by Hall, Rosbash and Young therefore reaches all the way to the hormone that gets you out of bed.
Beyond this central control, the peripheral clocks present in essentially every organ are entrained not only by the master clock but by feeding. When food timing and light exposure agree, central and peripheral clocks stay synchronised. Under shift work, jet lag or irregular eating they separate — and that internal desynchrony, rather than lost sleep alone, is increasingly understood to be where the metabolic harm originates.
Why This Discovery Matters: The Biology Beneath Jet Lag, Shift Work, and Disease
The practical significance of circadian genetics becomes obvious the moment you have experienced jet lag, pulled an all-nighter, or worked a rotating shift schedule. The disorientation, the impaired concentration, the disrupted appetite and digestion — these are not vague feelings of tiredness. They are the measurable, molecular consequence of your body’s cellular clocks falling out of synchronisation with each other and with the external environment.
According to a comprehensive review published in Nature Reviews Genetics in May 2026 titled “Time Matters: Circadian Genetics and the Molecular Logic of Human Health and Disease,” researchers now understand that approximately 50 percent of all mammalian genes are expressed on a 24-hour rhythm in at least one tissue, with their expression regulated in some way by the circadian clock machinery first described by Hall, Rosbash, and Young. This is a striking figure — it means that half of your genome is, in a meaningful biological sense, time-aware.
The medical implications of circadian disruption are now extensively documented. According to a 2026 review in the Journal of Clinical Investigation, disruption of clock gene expression is mechanistically linked to metabolic disease, including insulin resistance and type 2 diabetes, through disrupted timing of glucose and lipid metabolism. Research on the clock gene PER specifically has connected its abnormal expression to the regulation of blood pressure and the development of hypertension.
Shift workers, whose circadian clocks are chronically misaligned with their behavioural schedules, show measurably elevated rates of metabolic syndrome, cardiovascular disease, and certain cancers — associations strong enough that the World Health Organization’s International Agency for Research on Cancer has classified night shift work as a probable carcinogen, a classification that traces its scientific justification directly back to the molecular clock biology that Hall, Rosbash, and Young first described.
Chronotherapy: Timing Medicine to the Body’s Clock
One of the most active and clinically promising areas of current research built on the 2017 Nobel-winning discoveries is chronotherapy — the principle that the same drug, given at different times of day, can have meaningfully different efficacy and toxicity, because the cellular machinery it interacts with is itself rhythmic.
According to research published in npj Precision Oncology in December 2025, researchers have developed personalised chronotherapy protocols for glioblastoma, one of the most aggressive brain cancers, by integrating individual circadian profiling with pharmacokinetic modelling to optimise the timing of temozolomide chemotherapy administration. The model incorporates the patient’s own clock gene expression network to predict the treatment timing that will maximise tumour cell death while minimising damage to healthy tissue. A related 2025 meta-analysis published in the International Journal of Cancer examined chronotherapy in head and neck cancer, while research published in Clinical and Experimental Metastasis found that the time of day immunotherapy is administered measurably affects survival outcomes in metastatic kidney cancer.
Beyond cancer, researchers have begun engineering circadian biology directly into therapeutics. A study published in Nature Communications in February 2025 described the creation of a synthetic “chronogenetic” gene circuit — built using the core clock gene promoter Period2, one of the mammalian homologues of the original fly period gene — engineered into tissue-engineered cartilage implants designed to automatically release anti-inflammatory medication at the time of day when rheumatoid arthritis symptoms are typically most severe. The implanted cells continued to express genuine circadian rhythms even after implantation, entraining to the host’s daily light cycle and producing therapeutic drug concentrations on a predictable daily schedule — a striking practical descendant of the basic feedback-loop biology first worked out in fruit flies four decades earlier.
Circadian Genetics and the Biology of Aging
One of the most significant recent developments connects circadian rhythm research directly to the biology of aging — an area at the centre of this site’s coverage of telomeres and cellular aging and the genetics of exceptional longevity.
According to a 2026 review published in FEBS Letters detailing the biochemical mechanism of the mammalian circadian clock, the precision of cellular clock function deteriorates measurably with age, and this deterioration is mechanistically connected to several recognised hallmarks of aging, including chronic low-grade inflammation and impaired cellular waste clearance.
Separately, research published in Nature Cell Biology in early 2026 by Kris Burkewitz and colleagues at Vanderbilt University found that aging cells actively reshape their endoplasmic reticulum — reducing rough ER associated with protein production while preserving tubular ER linked to lipid metabolism — and that this restructuring process, called ER-phagy, directly influences lifespan. Notably, the timing and regulation of this cellular reorganisation is itself under circadian control, linking the clock genes discovered by Hall, Rosbash, and Young to one of the cell’s most fundamental aging-related maintenance systems.
This converges with a separate and striking 2026 finding published in Science by researchers at the Weizmann Institute’s Sagol Institute for Longevity Research, led by systems biologist Uri Alon. By statistically separating genetic from non-genetic causes of death more rigorously than previous studies, the team found that the heritability of human lifespan is approximately 50 percent once confounding environmental factors are properly accounted for — roughly double earlier estimates.
As lead researcher Noam Shenhar noted in comments accompanying the study, the modern world means we die far more from age-related diseases than from the infections and accidents that dominated mortality in earlier eras — meaning the genetic machinery governing the aging process itself, including the circadian systems first decoded in the 2017 Nobel-winning research, increasingly determines how long and how well we live.
What Genetic Variation in Your Own Clock Genes Means
Not everyone’s circadian clock runs identically. Some people are naturally early risers; others are night owls — a trait that has a substantial genetic basis rooted in variation within the same clock gene family that Hall, Rosbash, and Young first described.
According to research from Baylor College of Medicine’s Translational Research Institute for Space Health, published in August 2025, scientists are systematically cataloguing the human genetic variations that determine individual differences in 24-hour rhythmic gene expression and associated disease risk. The research has particular relevance for astronauts, for whom circadian misalignment during spaceflight poses a serious and well-documented health risk, but the same genetic variants are relevant to the general population’s sleep timing preferences, jet lag susceptibility, and vulnerability to shift-work-related disease.
This individual variation is also central to the emerging field of chrononutrition — the study of how meal timing interacts with an individual’s circadian genotype to affect metabolic health — and to broader efforts in personalised medicine that aim to time medical interventions, from medication dosing to light exposure therapy, to each patient’s specific circadian genetics rather than a generic daily schedule.
The largest attempt yet to map that variation was published in eBioMedicine in July 2026. Working with 312,935 UK Biobank participants, the team built a Circadian Imbalance Index — a simple 0 to 5 score combining evening chronotype, unusually short or long sleep, high neuroticism, atypical coffee intake and low vitamin D — and ran a genome-wide association study against it. They found 27 genetic regions, mapping to 72 genes, and the result held up in three separate cohorts. Two details matter for the general reader. Five of the genes showed up only when the components were analysed together, meaning the composite is not simply the sum of its parts; and the index was genetically correlated with insomnia, mood swings, body mass index, type 2 diabetes and coronary artery disease. Susceptibility to a disordered clock is not one gene or one mechanism. It is a polygenic disposition that travels with cardiometabolic and mood outcomes — which is a finding about populations, not a prediction about any individual reader.
What Scientists Say
Every quote below is reproduced verbatim from a primary, verifiable source, with the precise origin given for each.
“Their discoveries explain how plants, animals and humans adapt their biological rhythm so that it is synchronized with the Earth’s revolutions.”
— The Nobel Assembly at Karolinska Institutet, official press release awarding the 2017 Nobel Prize in Physiology or Medicine, 2 October 2017.
The committee emphasised that the molecular feedback loop the laureates described was not merely an explanation specific to fruit flies, but a fundamental and evolutionarily ancient mechanism present, with variations, across the vast majority of multicellular life.
Michael Rosbash, reflecting on the discovery in interviews following the Nobel announcement, has described the central insight — that a protein could regulate the timing of its own production through delayed negative feedback — as a beautifully simple solution to a problem that had resisted explanation for decades precisely because biologists had been searching for something more complicated. Michael Young has frequently emphasised in subsequent research and public commentary that the practical relevance of circadian genetics has, if anything, been underappreciated relative to its biological importance, given how directly it connects to sleep disorders, metabolic disease, and the timing-sensitivity of an enormous range of medical treatments.
According to the authors of the May 2026 Nature Reviews Genetics analysis, the field initiated by the 2017 Nobel-winning discoveries has moved decisively from basic mechanism toward clinical application, with sleep and circadian alignment now considered, alongside nutrition and physical activity, to be a primary pillar of preventative health rather than a peripheral concern.
Frequently Asked Questions
Further Reading on Web News For Us
Sources
Primary peer-reviewed research and the official Nobel record:
- The Nobel Prize (October 2, 2017) — The Nobel Prize in Physiology or Medicine 2017: Press Release
- The Nobel Assembly at Karolinska Institutet (2017) — Scientific Background: A 24-Hour Molecular Clockwork
- Konopka, R.J. & Benzer, S. (1971) — Clock Mutants of Drosophila melanogaster. PNAS 68(9):2112-6.
- Hardin, P.E., Hall, J.C. & Rosbash, M. (1990) — Feedback of the Drosophila period Gene Product on Circadian Cycling of Its Messenger RNA Levels. Nature 343(6258):536-40.
- Price, J.L., Blau, J., Rothenfluh, A., Abodeely, M., Kloss, B. & Young, M.W. (1998) — double-time Is a Novel Drosophila Clock Gene That Regulates PERIOD Protein Accumulation. Cell 94(1):83-95.
- Żebrowska, M. et al. (21 July 2026) — Genetic Architecture of a Circadian Imbalance Index: Genome-Wide Association, Phenome-Wide Association and Mendelian Randomisation Analyses. eBioMedicine 130:106380.
- Nature Reviews Genetics (May 15, 2026) — Time Matters: Circadian Genetics and the Molecular Logic of Human Health and Disease
- npj Precision Oncology (December 12, 2025) — Personalized Chronotherapy in Glioblastoma
- Nature Communications (February 7, 2025) — A Synthetic Chronogenetic Gene Circuit for Programmed Circadian Drug Delivery
- Journal of Clinical Investigation (2026) — Circadian Disruption, Clock Genes, and Metabolic Health
- Donahue, E.K.F. et al. (2026) — ER Remodelling Is a Feature of Ageing and Depends on ER-phagy. Nature Cell Biology. DOI: 10.1038/s41556-025-01860-1
- Shenhar, N. et al. (2026) — Heritability of Intrinsic Human Lifespan Is About 50%. Science 391(6784): 504. DOI: 10.1126/science.adz1187
- Baylor College of Medicine (August 12, 2025) — Genetics and Circadian Rhythms
- Ma, M.A., Morrison, E.H. (2026) — Neuroanatomy, Nucleus Suprachiasmatic. StatPearls, National Library of Medicine
- bioRxiv (January 23, 2026) — Functional Human Retinohypothalamic Tract Assembloid Model
- Fagiani, F. et al. (April 2025) — Circadian Rhythm Disruption, Melatonin, and Neurodegenerative Diseases. Molecules 30(9), 1888
- Graham, D.M., Wong, K.Y. — Melanopsin-Expressing ipRGCs. Webvision, University of Pittsburgh
Baryon. (2025, June 9). Circadian Rhythm Genetics: The 2017 Medicine Nobel Prize Explained. Web News For Us. https://webnewsforus.com/circadian-rhythm-genetics-2017-nobel-prize/
Baryon. “Circadian Rhythm Genetics: The 2017 Medicine Nobel Prize Explained.” Web News For Us, 9 June 2025, https://webnewsforus.com/circadian-rhythm-genetics-2017-nobel-prize/. Accessed 30 September 2026.
